Keith Katkin - 30 Sep 2022 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Director
Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
30 Sep 2022
Net transactions value
-$69,534
Form type
4
Filing time
04 Oct 2022, 17:49:07 UTC
Previous filing
05 Apr 2022
Next filing
07 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $22,962 +2,914 +9.1% $7.88 34,914 30 Sep 2022 Direct
transaction SNDX Common Stock Sale $73,056 -2,914 -8.3% $25.07 32,000 30 Sep 2022 Direct F1, F2
transaction SNDX Common Stock Options Exercise $5,778 +647 +2% $8.93 32,647 30 Sep 2022 Direct
transaction SNDX Common Stock Sale $16,221 -647 -2% $25.07 32,000 30 Sep 2022 Direct F1, F2
transaction SNDX Common Stock Options Exercise $1,316 +167 +0.52% $7.88 32,167 03 Oct 2022 Direct
transaction SNDX Common Stock Sale $4,175 -167 -0.52% $25.00 32,000 03 Oct 2022 Direct F1, F3
transaction SNDX Common Stock Options Exercise $116 +13 +0.04% $8.93 32,013 03 Oct 2022 Direct
transaction SNDX Common Stock Sale $325 -13 -0.04% $25.00 32,000 03 Oct 2022 Direct F1, F3
transaction SNDX Common Stock Options Exercise $1,080 +137 +0.43% $7.88 32,137 04 Oct 2022 Direct
transaction SNDX Common Stock Sale $3,425 -137 -0.43% $25.00 32,000 04 Oct 2022 Direct F1, F3
transaction SNDX Common Stock Options Exercise $1,991 +223 +0.7% $8.93 32,223 04 Oct 2022 Direct
transaction SNDX Common Stock Sale $5,575 -223 -0.69% $25.00 32,000 04 Oct 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -647 -100% $0.000000* 0 30 Sep 2022 Common Stock 647 $8.93 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -2,914 -100% $0.000000* 0 30 Sep 2022 Common Stock 2,914 $7.88 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -13 -100% $0.000000* 0 03 Oct 2022 Common Stock 13 $8.93 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -167 -100% $0.000000* 0 03 Oct 2022 Common Stock 167 $7.88 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -223 -100% $0.000000* 0 04 Oct 2022 Common Stock 223 $8.93 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -137 -100% $0.000000* 0 04 Oct 2022 Common Stock 137 $7.88 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 102,899 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested.
F2 The sale prices ranged from $25.00 to $25.215.
F3 The sale price was $25.00.
F4 This option is fully vested.